HIGHLIGHTS
- who: Findings et al. from the Abbreviations BEAM: Beads, Emulsification, Amplification and Magnetics have published the research work: Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade, in the Journal: (JOURNAL)
- future: Although these findings require further prospective analysis and validation in larger numbers of patients an easily-measured accurate plasma-based marker of disease such as ctDNA would potentially change patient management in several settings. Prospective analysis is required to assess the utility of ctDNA as an early biomarker of clinical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.